CN Bio and LifeNet Health LifeSciences partner to supply validated primary human cells for microphysiological systems

Partnership to provide customers with direct access to portfolio of highly characterized hepatic cells to recreate advanced Liver-on-a-Chip assays.

Trump 2.0 could see a rise in biopharmaceutical M&A deals – Pharmaceutical Technology

The second Trump administration is expected to focus on domestic M&A. Credit Brandon Bell / Getty Images. Trump’s return to the White House will mean

December 5, 2024

Moving beyond ChatGPT: How generative AI is inspiring dreams of a health data revolution

The world’s largest technology companies are racing to build generative AI into every corner of health and medicine. Microsoft has formed an alliance with the

September 5, 2023

EHR ‘Nudge’ Cut Low-Value Surgery Rates in Older Breast Cancer Patients

A “nudge” intervention in an electronic health record (EHR) significantly reduced rates of low-value axillary surgery in older women with early-stage, clinically node-negative breast cancer,

July 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.